NEW YORK–Attorney Advertising. The law firm of Wolf Haldenstein Adler Freeman & Herz LLP is investigating possible breaches of fiduciary duty by the Board of Directors of Caliper Life Sciences, Inc. (“Caliper” or the “Company”) (NASDAQ:CALP) arising out of the proposed acquisition of Caliper by PerkinElmer, Inc. (“PKI”).

On Thursday, September 8, 2011, PKI announced that PKI will acquire Caliper pursuant to an all cash offer. Under the terms of the agreement, Caliper stockholders will receive cash of $10.50 in exchange for each share of Caliper common stock. However, the Company may not have adequately shopped itself before entering into this transaction and, pursuant to this proposed transaction, PKI may be underpaying for Caliper, thus unlawfully harming Caliper shareholders.

Wolf Haldenstein has been representing individual and institutional investors for many years, serving as lead counsel in numerous cases in U.S. federal and state courts. Please visit the Wolf Haldenstein website (https://www.whafh.com) for more information about the firm.